TA-65 Anti-aging claims nonsense

Posted 28 February 2018

TA-65 is being sold in South Africa with claims that “a double-blind, placebo controlled study of TA-65® showed improvements in immune system,vision,male sexual performance,skin appearance and more”. The website claims: “A Breakthrough in Cell Rejuvenation”. 

According to WhoIs, the domain name is registered to Dr Ahmed Haffejie, “an Anti Aging Specialist”, of Midrand City, Halfway House. The product is imported by Zenith Biomedical who also imports another dubious product, Prevagen.

Are the claims true, and the product of any use?

Not according to the USA Federal Trade Commission which has barred the CEO of the company in the USA, Telomerase Activation Sciences, from making false and unsupported health claims for their products which includes TA-65 and TA-65MD.

Telomerase Activation Sciences and its CEO, Noel Thomas Patton, have agreed in a settlement order to stop making in its advertising unsubstantiated claims about the health benefits, performance, efficacy, safety, or side effects for two “anti-aging” products described in an administrative complaint by the Federal Trade Commission that the company falsely advertised that its products TA-65MD, which comes in capsule and powder forms, and its TA-65 for Skin (TA-65 Skin), a topical cream, reverse aging.

TA Sciences has agreed not to:

  • advertise unsubstantiated claims about the health benefits, performance, efficacy, safety, or side effects for any drug, food, dietary supplement, or cosmetic, and specifically, TA-65MD and TA-65 Skin
  • misrepresent any such products to be clinically proven to reverse human aging, prevent or repair DNA damage, restore aging immune systems, increase bone density, or misrepresent that such evidence or studies exists
  • misrepresent that any paid commercial advertising is independent programing
  • fail to disclose any material connection between a product endorser and the company
  • help anyone else make false or misleading health and efficacy claims

TA Sciences is also required to notify its licensees of the order, monitor the ads of its highest-selling licensees to ensure compliance, terminate any licensee who continues to make prohibited claims, and, within 30 days, notify consumers who bought TA-65MD or TA-65 Skin directly from the company within the past year or through an active continuity program about the FTC order.

Reference: New York-based supplement seller barred from false and unsupported health claims. FTC News Release, Feb 21, 2018

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>




This site uses Akismet to reduce spam. Learn how your comment data is processed.